Literature DB >> 30151269

Overexpression of SSH1 in gastric adenocarcinoma and its correlation with clinicopathological features.

Seyedeh Saideh Daryabari1, Reza Safaralizadeh1, Mohammadali Hosseinpourfeizi1, Yaghoub Moaddab2, Behrooz Shokouhi3.   

Abstract

BACKGROUND: Gastric adenocarcinoma is known to be the fourth most common cancer type and the second cause of cancer-related deaths. Movement and invasion of cancer cells is one of the major characteristics of the cancer phenotype that various types of network regulate this. Expression levels of slingshot diphosphatase 1 (SSH1) gene has been modulated in this pathway. SSH1 acts as a dephosphorylation and activator of cofilin that this regulating and activating by SSH1 can play a major role in the mobility and migration of the cell. The aim of this study was to compare the expression level of SSH1 genes between tumor and corresponding adjacent non tumor gastric tissues and healthy tissue of gastric adenocarcinoma.
METHODS: In this study, mRNA of 40 gastric adenocarcinoma and corresponding adjacent non tumor gastric tissues and 15 healthy biopsy samples was extracted, then after cDNA synthesis, real-time polymerase chain reaction was performed to measure gene expression.
RESULTS: According to REST analysis, the relative expression of SSH1 was significantly increased in gastric cancer tissues compared to the corresponding adjacent non tumor gastric tissue samples and normal tissue. Nevertheless, the result revealed no substantial correlation between the expression levels of SSH1 with clinical features. The biomarker index for SSH1 was obtained as 0.89.
CONCLUSIONS: The results obtained from investigating SSH1 expression are indicative of significant changes in the expression of this gene in gastric adenocarcinoma. This gene can also be used as a biomarker for gastric cancer.

Entities:  

Keywords:  Slingshot diphosphatase (SSH1); biomarker; expression; gastric adenocarcinoma

Year:  2018        PMID: 30151269      PMCID: PMC6087870          DOI: 10.21037/jgo.2018.03.09

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  25 in total

Review 1.  Familial gastric cancer: overview and guidelines for management.

Authors:  C Caldas; F Carneiro; H T Lynch; J Yokota; G L Wiesner; S M Powell; F R Lewis; D G Huntsman; P D Pharoah; J A Jankowski; P MacLeod; H Vogelsang; G Keller; K G Park; F M Richards; E R Maher; S A Gayther; C Oliveira; N Grehan; D Wight; R Seruca; F Roviello; B A Ponder; C E Jackson
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

2.  Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis.

Authors:  Seon Young Lee; Wooil Kim; Young Geun Lee; Hyo Jin Kang; Sang-Hyun Lee; Sun Young Park; Jeong-Ki Min; Sang-Rae Lee; Sang J Chung
Journal:  Pharmacol Res       Date:  2017-03-06       Impact factor: 7.658

3.  Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration.

Authors:  Yufeng Wang; Yasuhiro Kuramitsu; Takao Kitagawa; Byron Baron; Shigefumi Yoshino; Shin-Ichiro Maehara; Yoshihiko Maehara; Masaaki Oka; Kazuyuki Nakamura
Journal:  Cancer Lett       Date:  2015-02-12       Impact factor: 8.679

Review 4.  Cofilin phosphatases and regulation of actin dynamics.

Authors:  Timothy Y Huang; Céline DerMardirossian; Gary M Bokoch
Journal:  Curr Opin Cell Biol       Date:  2005-12-07       Impact factor: 8.382

5.  Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography.

Authors:  Sung Wook Hwang; Dong Ho Lee; Sang Hyub Lee; Young Soo Park; Jin Hyeok Hwang; Jin Wook Kim; Sook Hyang Jung; Na Young Kim; Young Hoon Kim; Kyoung Ho Lee; Hyung-Ho Kim; Do Joong Park; Hye Seung Lee; Hyun Chae Jung; In Sung Song
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

6.  Differential activities, subcellular distribution and tissue expression patterns of three members of Slingshot family phosphatases that dephosphorylate cofilin.

Authors:  Yusaku Ohta; Kazuyoshi Kousaka; Kyoko Nagata-Ohashi; Kazumasa Ohashi; Aya Muramoto; Yasuyuki Shima; Ryusuke Niwa; Tadashi Uemura; Kensaku Mizuno
Journal:  Genes Cells       Date:  2003-10       Impact factor: 1.891

Review 7.  Gastric cancer: diagnosis and treatment options.

Authors:  John C Layke; Peter P Lopez
Journal:  Am Fam Physician       Date:  2004-03-01       Impact factor: 3.292

Review 8.  The cofilin pathway in breast cancer invasion and metastasis.

Authors:  Weigang Wang; Robert Eddy; John Condeelis
Journal:  Nat Rev Cancer       Date:  2007-06       Impact factor: 60.716

9.  Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential.

Authors:  D Nowak; A J Mazur; A Popow-Woźniak; A Radwańska; H G Mannherz; M Malicka-Błaszkiewicz
Journal:  Eur J Histochem       Date:  2010-04-13       Impact factor: 3.188

10.  The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors.

Authors:  Weigang Wang; Ghassan Mouneimne; Mazen Sidani; Jeffrey Wyckoff; Xiaoming Chen; Anastasia Makris; Sumanta Goswami; Anne R Bresnick; John S Condeelis
Journal:  J Cell Biol       Date:  2006-05-01       Impact factor: 10.539

View more
  2 in total

1.  Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation.

Authors:  Mahafarin Maralani; Dariush Shanehbandi; Milad Asadi; Shahriar Hashemzadeh; Khalil Hajiasgharzadeh; Hossein Mashhadi Abdolahi; Behzad Baradaran; Marc Peeters
Journal:  Wien Klin Wochenschr       Date:  2021-08-31       Impact factor: 1.704

2.  Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells.

Authors:  Yang He; Cunlong Wang; Xiulin Zhang; Xuancheng Lu; Jin Xing; Jianyi Lv; Meng Guo; Xueyun Huo; Xin Liu; Jing Lu; Xiaoyan Du; Changlong Li; Zhenwen Chen
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.